Team:UQ-Australia/Parts
From 2011.igem.org
Line 1: | Line 1: | ||
{{:Team:UQ-Australia/Template:Header}} | {{:Team:UQ-Australia/Template:Header}} | ||
- | {| | + | {|style="width:100%;" border="0" cellpadding="10" cellspacing="0" |
- | |The human circadian rhythm drives many important processes in the body in accordance with the sleep/wake cycle. A characteristic of this biological clock is the periodic oscillation of gene expression. Current parts in the Registry designed to regulate periodic oscillations of gene expression have shown limited success. | + | |rowspan="2"|The human circadian rhythm drives many important processes in the body in accordance with the sleep/wake cycle. A characteristic of this biological clock is the periodic oscillation of gene expression. Current parts in the Registry designed to regulate periodic oscillations of gene expression have shown limited success. |
Here we demonstrate a biological clock being standardised as a set of BioBrick parts. | Here we demonstrate a biological clock being standardised as a set of BioBrick parts. | ||
- | + | ||
- | + | ||
- | + | ||
Our network is controlled by an engineered promoter, Plac/ara, which features both an activator and a repressor domain. This controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2, eventually leading to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression. This project shows the feasibility of standardising the biological clock in E. coli and grounds further development for applications in regulated drug/hormone delivery and ion channel control. | Our network is controlled by an engineered promoter, Plac/ara, which features both an activator and a repressor domain. This controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2, eventually leading to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression. This project shows the feasibility of standardising the biological clock in E. coli and grounds further development for applications in regulated drug/hormone delivery and ion channel control. | ||
+ | ! width="125" |[[File:IGEM basic Logo stylized.png|125x125px|link=https://2011.igem.org]] | ||
+ | |- | ||
|[[File:UQ-Australia_logo_2011.png|125x125px|link=https://2011.igem.org/Team:UQ-Australia]] | |[[File:UQ-Australia_logo_2011.png|125x125px|link=https://2011.igem.org/Team:UQ-Australia]] | ||
- | |||
|} | |} | ||
Line 42: | Line 41: | ||
|'''<span style="color:#D4A017">GlnAp2</span>''' | |'''<span style="color:#D4A017">GlnAp2</span>''' | ||
Promoter driven by phosphorylated GlnG(NR1) | Promoter driven by phosphorylated GlnG(NR1) | ||
- | |||
- | |||
- | |||
|} | |} | ||
Revision as of 12:03, 4 October 2011